Harrow Inc., a Nashville-based healthcare company specializing in ophthalmic pharmaceuticals, is navigating market volatility and financial challenges, but remains committed to advancing treatments for eye conditions despite a decline in its stock p…

Harrow Inc., a pharmaceutical company specializing in ophthalmic products, has established itself as a leader in the industry through its commitment to innovation and addressing unmet medical needs, with a strong financial foundation and promising f…

Harrow Inc., a pharmaceutical company specializing in ophthalmic treatments, is facing financial instability and a negative price-to-earnings ratio, raising concerns about its long-term viability.